Chocoladefabriken Lindt & Sprüngli AG (SWX:LISP)

CTI BioPharma Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,470	23,214	23,697	21,980	29,923	20,373
Market Cap Growth	27.65%	-2.04%	7.81%	-26.54%	46.87%	6.64%
Enterprise Value	28,891	24,491	24,636	22,648	30,248	20,946
Last Close Price	11980.00	9945.27	9831.13	9081.42	12029.96	8113.43
PE Ratio	42.71	34.53	35.29	38.58	61.01	63.33
PS Ratio	4.82	4.18	4.53	4.40	6.49	5.05
PB Ratio	5.77	4.80	5.57	5.00	5.73	4.42
P/TBV Ratio	7.80	6.59	7.85	7.14	7.64	6.17
P/FCF Ratio	53.38	25.43	47.57	39.91	49.08	36.27
P/OCF Ratio	35.13	19.64	30.44	29.08	36.19	25.87
EV/Sales Ratio	5.07	4.41	4.71	4.53	6.56	5.19
EV/EBITDA Ratio	25.32	22.65	24.62	24.42	36.65	34.44
EV/EBIT Ratio	33.09	27.03	29.82	30.04	46.61	47.69
EV/FCF Ratio	56.14	26.83	49.46	41.13	49.61	37.29
Debt / Equity Ratio	0.36	0.34	0.33	0.33	0.28	0.32
Debt / EBITDA Ratio	1.48	1.43	1.31	1.43	1.64	2.15
Debt / FCF Ratio	3.29	1.82	2.82	2.61	2.43	2.60
Asset Turnover	0.69	0.65	0.66	0.59	0.54	0.50
Inventory Turnover	1.55	2.04	1.90	2.05	2.08	1.96
Quick Ratio	0.71	1.18	0.88	1.25	1.51	1.74
Current Ratio	1.71	1.77	1.42	1.83	2.04	2.31
Return on Equity (ROE)	14.15%	14.78%	15.51%	11.84%	9.98%	6.90%
Return on Assets (ROA)	6.61%	6.66%	6.53%	5.58%	4.77%	3.41%
Return on Capital (ROIC)	8.75%	9.31%	8.98%	7.51%	6.35%	4.49%
Return on Capital Employed (ROCE)	12.20%	12.70%	13.70%	11.80%	8.70%	6.50%
Earnings Yield	2.34%	2.90%	2.83%	2.59%	1.64%	1.58%
FCF Yield	1.87%	3.93%	2.10%	2.50%	2.04%	2.76%
Dividend Yield	1.25%	15.08%	14.24%	14.31%	9.98%	13.56%
Payout Ratio	53.61%	47.85%	45.22%	49.87%	53.84%	129.81%
Buyback Yield / Dilution	0.01%	1.20%	1.60%	1.74%	0.19%	-1.42%
Total Shareholder Return	1.25%	16.28%	15.84%	16.06%	10.17%	12.14%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.